Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 14;11(4):20458940211053196.
doi: 10.1177/20458940211053196. eCollection 2021 Oct-Dec.

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)

Affiliations

Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR)

Jasleen Minhas et al. Pulm Circ. .

Erratum in

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, morbid, potentially curable subtype of pulmonary hypertension that negatively impacts health-related quality of life (HRQoL). Little is known about differences in HRQoL and hospitalization between CTEPH patients and idiopathic pulmonary arterial hypertension (IPAH) patients. Using multivariable linear regression and mixed effects models, we examined differences in HRQoL assessed by emPHasis-10 (E10) and SF-12 between CTEPH and IPAH patients in the Pulmonary Hypertension Association Registry, a prospective multicenter cohort of patients newly evaluated at a Pulmonary Hypertension Care Center. Multivariable negative binomial regression models were used to estimate incidence rate ratios (IRR) for hospitalization amongst the two groups. We included 461 IPAH patients and 169 CTEPH patients. Twenty-one percent of CTEPH patients underwent pulmonary thromboendarterectomy (PTE) before the end of follow-up. At baseline, patients with CTEPH had significantly worse HRQoL (higher E10 scores) (ß 2.83, SE 1.11, p = 0.01); however, differences did not persist over time. CTEPH patients had higher rates of hospitalization (excluding the hospitalization for PTE) compared to IPAH patients after adjusting for age, sex, body mass index, WHO functional class and six-minute walk distance (IRR 1.66, 95%CI 1.04-2.65, p = 0.03). CTEPH patients who underwent PTE had improved HRQoL as compared to those who were medically managed, but patients who underwent PTE were younger, had higher cardiac outputs and greater six-minute walk distances. In this large, prospective, multicenter cohort, CTEPH patients had significantly worse baseline HRQoL and higher rates of hospitalizations than those with IPAH. CTEPH patients who underwent PTE had significant improvements in HRQoL.

Keywords: hospitalizations; pulmonary thromboendarterectomy; quality of life.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Flow diagram for study participants.
Fig. 2.
Fig. 2.
Expected mean estimates for patients with IPAH vs. CTEPH of (a) emPHasis-10 scores, (b) Short Form-12 physical component and (c) Short Form-12 mental component scores at the time of enrollment adjusted for age, sex, BMI, six-minute walk distance and WHO functional class.
Fig. 3.
Fig. 3.
Expected mean estimates for patients with IPAH vs. CTEPH of (a) emPHasis-10 scores, (b) Short Form-12 physical component and (c) Short Form-12 mental component scores over time adjusted for age, sex, BMI, six-minute walk distance, WHO functional class and pulmonary thromboendarterectomy status.
Fig. 4.
Fig. 4.
Cumulative mean hospitalizations over time in patients with chronic thromboembolic pulmonary hypertension (CTEPH) vs. those with idiopathic pulmonary arterial hypertension (IPAH).
Fig. 5.
Fig. 5.
Spaghetti plot of emPHasis-10 scores for individual patients with chronic thromboembolic pulmonary hypertension (CTEPH) (a) post-pulmonary thromboendarterectomy  (PTE) and (b) medical management only.
Fig. 6.
Fig. 6.
Expected unadjusted mean estimates for patients with CTEPH who underwent pulmonary thromboendarterectomy (PTE) vs. those who were medically managed of (a) emPHasis-10 scores, (b) Short Form-12 physical component and (c) Short Form-12 mental component scores over time.

References

    1. Strange G, Playford D, Stewart S, et al. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart 2012; 98: 1805–1811. - PMC - PubMed
    1. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637. - PubMed
    1. Mathai SC, Suber T, Khair RM, et al. Health-related quality of life and survival in pulmonary arterial hypertension. Ann Am Thorac Soc 2016; 13: 31–39. - PMC - PubMed
    1. Jenkins D, Madani M, Fadel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26: 160111. - PMC - PubMed
    1. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev 2010; 19: 59–63. - PMC - PubMed

LinkOut - more resources